Inventor · disambiguated record
Jeffrey Wallin
Also filed as: WALLIN JEFFREY
5 granted patents·8 pending applications·98 citations·filing 2008–2022
82Inventor score
Top patents by PatentIndex Score
13 records- 0196US9107926B2Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancerGENENTECH INC·Filed 2013·Granted Aug 18, 2015·28 cites·11 claims
- 0292US8247397B2Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of useBELVIN MARCIA·Filed 2008·Granted Aug 21, 2012·40 cites·34 claims
- 0391US8604014B2Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of useBELVIN MARCIA·Filed 2011·Granted Dec 10, 2013·26 cites·15 claims
- 0483US10092567B2Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of useGENENTECH INC·Filed 2017·Granted Oct 9, 2018·3 cites·10 claims
- 0573US9717730B2Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of useGENENTECH INC·Filed 2016·Granted Aug 1, 2017·1 cites·10 claims
- 0672US2023340613A1Methods for monitoring and treating cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 0763US2018280408A1Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancerGENENTECH INC·Filed 2018·Application pending·0 cites
- 0859US2019032151A1Methods for monitoring and treating cancerGENENTECH INC·Filed 2018·Application pending·0 cites
- 0956US2016045515A1Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancerGENENTECH INC·Filed 2015·Application pending·0 cites
- 1054US2013345217A1Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of useGENENTECH INC·Filed 2013·Application pending·0 cites
- 1144US2019038734A1Methods for monitoring and treating cancerGENENTECH INC·Filed 2018·Application pending·0 cites
- 1236US2016279142A1Combinations of a phosphoinositide 3-kinase inhibitor compound and a cdk4/6 inhibitor compound for the treatment of cancerGENENTECH INC·Filed 2016·Application pending·0 cites
- 1334US2011086837A1Combinations of a pi3k inhibitor and a mek inhibitorGENENTECH INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey Wallin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →